Annual EBIT
-$18.24 M
+$7.54 M+29.24%
December 31, 2023
Summary
- As of March 12, 2025, BIOL annual earnings before interest & taxes is -$18.24 million, with the most recent change of +$7.54 million (+29.24%) on December 31, 2023.
- During the last 3 years, BIOL annual EBIT has fallen by -$3.90 million (-27.18%).
Performance
BIOL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$811.00 K
+$1.38 M+63.00%
September 30, 2024
Summary
- As of March 12, 2025, BIOL quarterly earnings before interest & taxes is -$811.00 thousand, with the most recent change of +$1.38 million (+63.00%) on September 30, 2024.
- Over the past year, BIOL quarterly EBIT has increased by +$3.17 million (+79.60%).
Performance
BIOL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$13.59 M
+$3.17 M+18.90%
September 30, 2024
Summary
- As of March 12, 2025, BIOL TTM earnings before interest & taxes is -$13.59 million, with the most recent change of +$3.17 million (+18.90%) on September 30, 2024.
- Over the past year, BIOL TTM EBIT has increased by +$8.23 million (+37.72%).
Performance
BIOL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BIOL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.2% | +79.6% | +37.7% |
| 3 y3 years | -27.2% | +79.6% | +37.7% |
| 5 y5 years | +12.9% | +79.6% | +37.7% |
BIOL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +31.5% | +41.3% | at high | +925.0% | +13.9% | +96.7% |
| 5 y | 5-year | +31.5% | +41.3% | -236.3% | +925.0% | +19.6% | +96.7% |
| alltime | all time | -363.4% | +41.3% | -131.9% | +1072.5% | -290.3% | +96.7% |
BIOLASE EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$811.00 K(-63.0%) | -$13.59 M(-18.9%) |
| Jun 2024 | - | -$2.19 M(-62.5%) | -$16.75 M(-11.0%) |
| Mar 2024 | - | -$5.84 M(+23.3%) | -$18.81 M(+3.1%) |
| Dec 2023 | -$18.24 M(-29.2%) | -$4.74 M(+19.2%) | -$18.24 M(-16.4%) |
| Sep 2023 | - | -$3.98 M(-6.5%) | -$21.81 M(-15.5%) |
| Jun 2023 | - | -$4.25 M(-19.3%) | -$25.82 M(-3.4%) |
| Mar 2023 | - | -$5.27 M(-36.6%) | -$26.72 M(+3.7%) |
| Dec 2022 | -$25.78 M(+85.9%) | -$8.31 M(+4.2%) | -$25.78 M(+16.2%) |
| Sep 2022 | - | -$7.98 M(+54.7%) | -$22.17 M(+31.3%) |
| Jun 2022 | - | -$5.16 M(+19.2%) | -$16.89 M(+41.6%) |
| Mar 2022 | - | -$4.33 M(-8.2%) | -$11.93 M(-14.0%) |
| Dec 2021 | -$13.87 M(-3.3%) | -$4.71 M(+74.9%) | -$13.87 M(-5.3%) |
| Sep 2021 | - | -$2.69 M(+1246.5%) | -$14.64 M(+29.0%) |
| Jun 2021 | - | -$200.00 K(-96.8%) | -$11.36 M(-25.2%) |
| Mar 2021 | - | -$6.27 M(+14.2%) | -$15.18 M(+5.8%) |
| Dec 2020 | -$14.34 M(-8.9%) | -$5.49 M(-1022.0%) | -$14.35 M(+19.9%) |
| Sep 2020 | - | $595.00 K(-114.8%) | -$11.96 M(-31.5%) |
| Jun 2020 | - | -$4.02 M(-26.1%) | -$17.46 M(+4.0%) |
| Mar 2020 | - | -$5.44 M(+75.3%) | -$16.78 M(+6.5%) |
| Dec 2019 | -$15.74 M(-24.8%) | -$3.10 M(-36.7%) | -$15.75 M(-17.8%) |
| Sep 2019 | - | -$4.90 M(+46.6%) | -$19.17 M(+1.7%) |
| Jun 2019 | - | -$3.34 M(-24.2%) | -$18.85 M(-7.5%) |
| Mar 2019 | - | -$4.41 M(-32.4%) | -$20.37 M(-2.7%) |
| Dec 2018 | -$20.94 M(+19.4%) | -$6.52 M(+42.2%) | -$20.94 M(+12.3%) |
| Sep 2018 | - | -$4.58 M(-5.8%) | -$18.64 M(-0.9%) |
| Jun 2018 | - | -$4.87 M(-2.2%) | -$18.82 M(+2.1%) |
| Mar 2018 | - | -$4.98 M(+18.1%) | -$18.43 M(+5.1%) |
| Dec 2017 | -$17.53 M(+17.2%) | -$4.22 M(-11.4%) | -$17.53 M(+0.6%) |
| Sep 2017 | - | -$4.76 M(+6.3%) | -$17.43 M(+10.2%) |
| Jun 2017 | - | -$4.48 M(+9.9%) | -$15.82 M(+7.4%) |
| Mar 2017 | - | -$4.08 M(-0.9%) | -$14.72 M(-1.6%) |
| Dec 2016 | -$14.96 M(-27.5%) | -$4.11 M(+30.7%) | -$14.96 M(+14.0%) |
| Sep 2016 | - | -$3.15 M(-7.1%) | -$13.12 M(-14.4%) |
| Jun 2016 | - | -$3.39 M(-21.5%) | -$15.33 M(-19.2%) |
| Mar 2016 | - | -$4.31 M(+89.6%) | -$18.97 M(-8.1%) |
| Dec 2015 | -$20.65 M(+15.1%) | -$2.27 M(-57.5%) | -$20.65 M(-6.3%) |
| Sep 2015 | - | -$5.35 M(-23.9%) | -$22.02 M(+9.6%) |
| Jun 2015 | - | -$7.03 M(+17.3%) | -$20.10 M(+4.2%) |
| Mar 2015 | - | -$5.99 M(+64.0%) | -$19.30 M(+7.6%) |
| Dec 2014 | -$17.94 M(+63.2%) | -$3.65 M(+6.5%) | -$17.94 M(+10.5%) |
| Sep 2014 | - | -$3.43 M(-44.9%) | -$16.24 M(-2.5%) |
| Jun 2014 | - | -$6.22 M(+34.4%) | -$16.66 M(+31.0%) |
| Mar 2014 | - | -$4.63 M(+137.3%) | -$12.71 M(+15.6%) |
| Dec 2013 | -$11.00 M(+306.4%) | -$1.95 M(-49.2%) | -$11.00 M(+39.4%) |
| Sep 2013 | - | -$3.85 M(+68.4%) | -$7.89 M(+76.9%) |
| Jun 2013 | - | -$2.28 M(-21.7%) | -$4.46 M(+12.0%) |
| Mar 2013 | - | -$2.92 M(-352.7%) | -$3.98 M(+47.2%) |
| Dec 2012 | -$2.71 M(-33.9%) | $1.15 M(-377.4%) | -$2.71 M(-54.0%) |
| Sep 2012 | - | -$416.00 K(-77.0%) | -$5.88 M(-7.5%) |
| Jun 2012 | - | -$1.80 M(+10.1%) | -$6.36 M(+20.3%) |
| Mar 2012 | - | -$1.64 M(-18.9%) | -$5.29 M(+22.5%) |
| Dec 2011 | -$4.09 M(-64.7%) | -$2.02 M(+126.1%) | -$4.32 M(+119.0%) |
| Sep 2011 | - | -$894.00 K(+22.0%) | -$1.97 M(-45.5%) |
| Jun 2011 | - | -$733.00 K(+9.6%) | -$3.62 M(-48.2%) |
| Mar 2011 | - | -$669.00 K(-305.8%) | -$6.98 M(-39.8%) |
| Dec 2010 | -$11.60 M(+317.5%) | $325.00 K(-112.8%) | -$11.60 M(-12.9%) |
| Sep 2010 | - | -$2.54 M(-38.0%) | -$13.32 M(+34.3%) |
| Jun 2010 | - | -$4.10 M(-22.6%) | -$9.92 M(+187.0%) |
| Mar 2010 | - | -$5.29 M(+278.4%) | -$3.46 M(+24.4%) |
| Dec 2009 | -$2.78 M(-68.6%) | -$1.40 M(-261.6%) | -$2.78 M(-57.7%) |
| Sep 2009 | - | $865.00 K(-63.5%) | -$6.58 M(-44.5%) |
| Jun 2009 | - | $2.37 M(-151.3%) | -$11.85 M(-14.3%) |
| Mar 2009 | - | -$4.61 M(-11.2%) | -$13.83 M(+41.4%) |
| Dec 2008 | -$8.85 M | -$5.20 M(+18.0%) | -$9.78 M(+35.9%) |
| Sep 2008 | - | -$4.41 M(-1241.2%) | -$7.20 M(+12.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | $386.00 K(-168.8%) | -$6.38 M(-17.0%) |
| Mar 2008 | - | -$561.00 K(-78.5%) | -$7.69 M(-14.3%) |
| Dec 2007 | -$8.97 M(+85.4%) | -$2.62 M(-27.1%) | -$8.97 M(+66.0%) |
| Sep 2007 | - | -$3.59 M(+288.8%) | -$5.40 M(+83.3%) |
| Jun 2007 | - | -$923.00 K(-49.9%) | -$2.95 M(-34.0%) |
| Mar 2007 | - | -$1.84 M(-293.4%) | -$4.46 M(-7.8%) |
| Dec 2006 | -$4.84 M(-71.5%) | $953.00 K(-184.0%) | -$4.84 M(-28.7%) |
| Sep 2006 | - | -$1.13 M(-53.5%) | -$6.79 M(-37.4%) |
| Jun 2006 | - | -$2.44 M(+9.9%) | -$10.84 M(-27.4%) |
| Mar 2006 | - | -$2.22 M(+122.6%) | -$14.93 M(-12.0%) |
| Dec 2005 | -$16.98 M(+81.4%) | -$997.00 K(-80.8%) | -$16.98 M(-33.4%) |
| Sep 2005 | - | -$5.19 M(-20.6%) | -$25.49 M(+13.6%) |
| Jun 2005 | - | -$6.53 M(+53.2%) | -$22.45 M(+52.6%) |
| Mar 2005 | - | -$4.26 M(-55.1%) | -$14.71 M(+57.2%) |
| Dec 2004 | -$9.36 M(-235.2%) | -$9.51 M(+343.5%) | -$9.36 M(-482.2%) |
| Sep 2004 | - | -$2.14 M(-277.5%) | $2.45 M(-65.7%) |
| Jun 2004 | - | $1.21 M(+11.3%) | $7.14 M(+0.2%) |
| Mar 2004 | - | $1.08 M(-52.8%) | $7.12 M(+2.9%) |
| Dec 2003 | $6.92 M(+390.4%) | $2.30 M(-9.6%) | $6.92 M(+41.3%) |
| Sep 2003 | - | $2.54 M(+112.9%) | $4.90 M(+76.9%) |
| Jun 2003 | - | $1.20 M(+34.9%) | $2.77 M(+29.5%) |
| Mar 2003 | - | $886.00 K(+222.2%) | $2.14 M(+54.3%) |
| Dec 2002 | $1.41 M(-221.9%) | $275.00 K(-33.6%) | $1.39 M(+99.4%) |
| Sep 2002 | - | $414.00 K(-26.6%) | $695.00 K(+91.5%) |
| Jun 2002 | - | $564.00 K(+324.1%) | $363.00 K(-212.6%) |
| Mar 2002 | - | $133.00 K(-132.0%) | -$322.50 K(-72.1%) |
| Dec 2001 | -$1.16 M(-68.1%) | -$416.00 K(-607.3%) | -$1.16 M(-12.8%) |
| Sep 2001 | - | $82.00 K(-167.5%) | -$1.33 M(-48.1%) |
| Jun 2001 | - | -$121.50 K(-82.7%) | -$2.56 M(-22.9%) |
| Mar 2001 | - | -$702.40 K(+19.8%) | -$3.32 M(-8.6%) |
| Dec 2000 | -$3.63 M(-23.5%) | -$586.20 K(-49.0%) | -$3.63 M(-28.8%) |
| Sep 2000 | - | -$1.15 M(+30.0%) | -$5.10 M(+7.6%) |
| Jun 2000 | - | -$883.30 K(-13.1%) | -$4.74 M(-6.1%) |
| Mar 2000 | - | -$1.02 M(-50.5%) | -$5.05 M(+6.7%) |
| Dec 1999 | -$4.75 M(-6.9%) | -$2.05 M(+160.8%) | -$4.73 M(+10.6%) |
| Sep 1999 | - | -$787.20 K(-34.1%) | -$4.28 M(-14.3%) |
| Jun 1999 | - | -$1.19 M(+70.5%) | -$4.99 M(-0.1%) |
| Mar 1999 | - | -$700.00 K(-56.3%) | -$5.00 M(-2.0%) |
| Dec 1998 | -$5.10 M(+75.9%) | -$1.60 M(+6.7%) | -$5.10 M(+18.6%) |
| Sep 1998 | - | -$1.50 M(+25.0%) | -$4.30 M(+30.3%) |
| Jun 1998 | - | -$1.20 M(+50.0%) | -$3.30 M(+10.0%) |
| Mar 1998 | - | -$800.00 K(0.0%) | -$3.00 M(0.0%) |
| Dec 1997 | -$2.90 M(+16.0%) | -$800.00 K(+60.0%) | -$3.00 M(0.0%) |
| Sep 1997 | - | -$500.00 K(-44.4%) | -$3.00 M(-3.2%) |
| Jun 1997 | - | -$900.00 K(+12.5%) | -$3.10 M(+14.8%) |
| Mar 1997 | - | -$800.00 K(0.0%) | -$2.70 M(+8.0%) |
| Dec 1996 | -$2.50 M(+31.6%) | -$800.00 K(+33.3%) | -$2.50 M(+19.0%) |
| Sep 1996 | - | -$600.00 K(+20.0%) | -$2.10 M(+23.5%) |
| Jun 1996 | - | -$500.00 K(-16.7%) | -$1.70 M(+6.3%) |
| Mar 1996 | - | -$600.00 K(+50.0%) | -$1.60 M(-11.1%) |
| Dec 1995 | -$1.90 M(-51.3%) | -$400.00 K(+100.0%) | -$1.80 M(-37.9%) |
| Sep 1995 | - | -$200.00 K(-50.0%) | -$2.90 M(-19.4%) |
| Jun 1995 | - | -$400.00 K(-50.0%) | -$3.60 M(-2.7%) |
| Mar 1995 | - | -$800.00 K(-46.7%) | -$3.70 M(+37.0%) |
| Dec 1994 | -$3.90 M(-48.0%) | -$1.50 M(+66.7%) | -$2.70 M(-27.0%) |
| Sep 1994 | - | -$900.00 K(+80.0%) | -$3.70 M(-15.9%) |
| Jun 1994 | - | -$500.00 K(-350.0%) | -$4.40 M(-24.1%) |
| Mar 1994 | - | $200.00 K(-108.0%) | -$5.80 M(-22.7%) |
| Dec 1993 | -$7.50 M(+36.4%) | -$2.50 M(+56.3%) | -$7.50 M(+1.4%) |
| Sep 1993 | - | -$1.60 M(-15.8%) | -$7.40 M(+8.8%) |
| Jun 1993 | - | -$1.90 M(+26.7%) | -$6.80 M(+11.5%) |
| Mar 1993 | - | -$1.50 M(-37.5%) | -$6.10 M(+90.6%) |
| Dec 1992 | -$5.50 M | -$2.40 M(+140.0%) | -$3.20 M(+300.0%) |
| Sep 1992 | - | -$1.00 M(-16.7%) | -$800.00 K(-500.0%) |
| Jun 1992 | - | -$1.20 M(-185.7%) | $200.00 K(-85.7%) |
| Mar 1992 | - | $1.40 M | $1.40 M |
FAQ
- What is BIOLASE annual earnings before interest & taxes?
- What is the all time high annual EBIT for BIOLASE?
- What is BIOLASE annual EBIT year-on-year change?
- What is BIOLASE quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for BIOLASE?
- What is BIOLASE quarterly EBIT year-on-year change?
- What is BIOLASE TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for BIOLASE?
- What is BIOLASE TTM EBIT year-on-year change?
What is BIOLASE annual earnings before interest & taxes?
The current annual EBIT of BIOL is -$18.24 M
What is the all time high annual EBIT for BIOLASE?
BIOLASE all-time high annual earnings before interest & taxes is $6.92 M
What is BIOLASE annual EBIT year-on-year change?
Over the past year, BIOL annual earnings before interest & taxes has changed by +$7.54 M (+29.24%)
What is BIOLASE quarterly earnings before interest & taxes?
The current quarterly EBIT of BIOL is -$811.00 K
What is the all time high quarterly EBIT for BIOLASE?
BIOLASE all-time high quarterly earnings before interest & taxes is $2.54 M
What is BIOLASE quarterly EBIT year-on-year change?
Over the past year, BIOL quarterly earnings before interest & taxes has changed by +$3.17 M (+79.60%)
What is BIOLASE TTM earnings before interest & taxes?
The current TTM EBIT of BIOL is -$13.59 M
What is the all time high TTM EBIT for BIOLASE?
BIOLASE all-time high TTM earnings before interest & taxes is $7.14 M
What is BIOLASE TTM EBIT year-on-year change?
Over the past year, BIOL TTM earnings before interest & taxes has changed by +$8.23 M (+37.72%)